2022 article
Intensity of perioperative analgesia but not pre-treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma
Nolan, M. W., Uzan, O. C., Green, N. A., Lana, S. E., & Lascelles, B. D. X. (2022, March 21). VETERINARY AND COMPARATIVE ONCOLOGY.
author keywords: analgesia; cancer pain; cancer treatment pain; local anaesthesia; malignant osteolysis
MeSH headings : Amputation, Surgical / veterinary; Analgesia / veterinary; Animals; Anti-Inflammatory Agents, Non-Steroidal / therapeutic use; Bone Neoplasms / drug therapy; Bone Neoplasms / surgery; Bone Neoplasms / veterinary; Dog Diseases / drug therapy; Dog Diseases / surgery; Dogs; Extremities / surgery; Osteosarcoma / drug therapy; Osteosarcoma / surgery; Osteosarcoma / veterinary; Pain / drug therapy; Pain / veterinary; Retrospective Studies; Treatment Outcome
TL;DR:
In dogs treated with limb amputation and adjunctive chemotherapy for osteosarcoma, oncologic outcomes are impacted by either baseline cancer pain severity, or the approaches used for perioperative pain management.
(via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being
(Web of Science; OpenAlex)
Source: Web Of Science
Added: April 4, 2022
Abstract